Broker Research
June 10, 2025 / 13:00 IST
Reported Standalone quarterly numbers for Vista Pharmaceuticals are:Net Sales at Rs 3.23 crore in March 2025 up 3.11% from Rs. 3.13 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.50 crore in March 2025 down 1747.14% from Rs. 0.09 crore in March 2024.
EBITDA stands negative at Rs. 0.68 crore in March 2025 down 288.89% from Rs. 0.36 crore in March 2024.
Vista Pharma shares closed at 11.85 on June 09, 2025 (BSE) and has given 0.77% returns over the last 6 months and -10.57% over the last 12 months.
| Vista Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 3.23 | 2.56 | 3.13 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 3.23 | 2.56 | 3.13 | | EXPENDITURE | | Consumption of Raw Materials | 2.69 | 2.05 | 1.49 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | 0.45 | 0.01 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.56 | 0.52 | 0.48 | | Depreciation | 0.18 | 0.19 | 0.18 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.89 | 1.06 | 0.89 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.10 | -1.70 | 0.08 | | Other Income | 0.24 | 0.12 | 0.10 | | P/L Before Int., Excpt. Items & Tax | -0.86 | -1.58 | 0.18 | | Interest | 0.21 | 0.22 | 0.28 | | P/L Before Exceptional Items & Tax | -1.06 | -1.80 | -0.10 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -1.06 | -1.80 | -0.10 | | Tax | 0.43 | -0.48 | -0.19 | | P/L After Tax from Ordinary Activities | -1.50 | -1.32 | 0.09 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.50 | -1.32 | 0.09 | | Equity Share Capital | 12.31 | 12.31 | 9.43 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.79 | -0.07 | 0.02 | | Diluted EPS | -0.79 | -0.07 | 0.01 | | EPS After Extra Ordinary | | Basic EPS | -0.79 | -0.07 | 0.02 | | Diluted EPS | -0.79 | -0.07 | 0.01 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
